0
0
India is witnessing a rising burden of Inflammatory Bowel Disease (IBD), with experts emphasizing the urgent need for patient-centric care models and trained counsellors to manage this complex condition effectively. In 2019, India recorded 4,214 deaths related to IBD, highlighting the disease’s significant health impact.
IBD, which includes Crohn’s Disease and Ulcerative Colitis, shows a changing epidemiological pattern in India. The incidence rate is increasing, particularly among males and older age groups, with the highest incidence observed in people aged 50–74 years and a sharp rise in those over 751. Although prevalence and incidence rates remain lower than global averages, the annual rate of change in India is among the highest worldwide, signaling a growing public health concern.
Experts point to several challenges in India’s IBD management:
-
Delayed Diagnosis: Patients often face diagnostic delays of two to three years, visiting multiple doctors before receiving an accurate diagnosis, which leads to disease progression and complications in about 70% of cases.
-
Misdiagnosis with Intestinal Tuberculosis: Confusion between IBD and intestinal tuberculosis leads to inappropriate treatments, worsening patient outcomes.
-
Lack of Awareness and Guidelines: There is a critical absence of standardized national guidelines and awareness programs, hampering early diagnosis and effective management.
-
High Treatment Costs: Most treatments rely on imported drugs, imposing a heavy financial burden on patients and families.
-
Need for Multidisciplinary Care: Experts advocate for integrated care centers involving gastroenterologists, surgeons, psychologists, and dieticians to address the physical and psychological aspects of IBD.
Forecasts suggest a four-fold increase in IBD prevalence in India by 2050, with over 450,000 cases expected, underscoring the urgency for policy action and healthcare infrastructure development.
Leading gastroenterologists urge the government to establish clear guidelines for early diagnosis, improve research and development of indigenous treatments, and promote patient education to reduce the disease burden and improve quality of life for those affected.
Disclaimer: This article is based on current research and expert opinions as of 2024. The epidemiology and management of IBD are evolving fields; readers should consult healthcare professionals for personalized medical advice.
Citations:
